This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cambrex Corp (CBM)

NYSE: Health Care

Company Cash Flow
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Cash Flow From Operating Activities
Net Income (Loss) 57.22M 57.30M 25.91M 62.30M
Operating Gains/Losses 0.00 10.69M -2.02M 1.77M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -14.38M -8.96M -27.71M -6.31M
(Increase) Decrease in Inventories -32.72M -9.06M -19.33M -10.29M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 10.33M 12.37M 10.11M 3.13M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 6.85M 9.39M 29.87M 10.69M
Other Non-Cash Items 11.78M -6.94M -4.16M 5.13M
Net Cash From Continuing Operations 85.14M 66.83M 38.41M 47.29M
Net Cash From Discontinued Operations -1.54M -1.86M -1.53M -3.75M
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 83.61M 64.97M 36.87M 43.55M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -62.49M -23.32M -57.32M -18.16M
Acquisitions 0.00 -2.43M 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 2.25M 951.00K 723.00K -2.03M
Cash Provided by Financing Activities
Net Cash From Investing Activities -60.24M -24.80M -56.60M -20.18M
Issuance of Debt 0.00 25.75M 70.95M 5.50M
Cash Used for Financing Activities
Issuance of Capital Stock 5.82M 4.20M 3.22M 1.35M
Repayment of Long-Term Debt -30.00M -45.00M -55.70M -39.50M
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 1.45M 522.00K -301.00K -22.00K
Net Cash From Financing Activities -22.74M -14.53M 18.17M -32.67M
Effect of Exchange Rate Changes -2.17M -2.87M 744.00K 933.00K
Net Change in Cash & Cash Equivalents -1.54M 22.77M -806.00K -8.37M
CBM News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for CBM

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET CBM ANALYST REPORT

CBM Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs